A Blueprint to Understand Executive Authority on Allowing Safe Personal Drug Importation
Today, President Trump announced four executive orders with the stated intent of substantially lowering drug prices. Briefly, the administration’s bluster on drug prices over the past three years has been far louder than any actions taken to actually do something about it. Better late than never.
The orders call for and include: 1) Lower prices on EpiPens and insulin, 2) Allowing personal drug importation, 3) Ending profit-taking by pharmacy benefit manager middlemen, and 4) “most favored nation” drug price negotiation in Medicare, meaning Medicare would get the lowest price on drugs of any country.
Obviously, we need more details to analyze the orders, but we’ve done substantial research into executive authorities specifically on personal drug importation. During the signing ceremony, Secretary of the Department of Health and Human Services Alex Azar clearly stated: “You’re going to have a personal importation program, where individuals can get their drugs low cost from abroad.”
Here is the Prescription Justice full policy paper on executive actions on personal drug importation.
How the Trump Administration Can Rapidly Lower Drug Costs for Americans
Tags
Archives
- All
- January 2024
- April 2023
- October 2022
- September 2022
- August 2022
- June 2022
- April 2022
- January 2022
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- October 2020
- September 2020
- August 2020
- July 2020
- March 2020
- February 2020
- December 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- April 2019
- February 2019
- December 2018
- September 2018
- June 2018
- May 2018
- April 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- November 2015